Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 15 (TRBV15) is a protein coding gene that encodes one of the variable regions of the beta chain of the T cell receptor (TCR) complex in humans. The TCR complex is critical for the adaptive immune system, enabling T cells to recognize and respond to a wide array of antigens presented by major histocompatibility complex (MHC) molecules on the surfaces of other cells. TRBV15 specifically contributes to the antigen-binding diversity of TCRs by offering unique variable (V) gene segment sequences, generated through somatic recombination with other TCR gene segments. As such, TRBV15 plays a role in immune surveillance, autoimmune risk, infection control, and is increasingly studied in cancer immunotherapy and adoptive T cell therapies, where TCR gene segments are harnessed for tumor antigen targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 15 (TRBV15).